About: Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2006 (uk) im Mai 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2006 (ast) scientific article published on 01 May 2006 (en)
publication date	wds:Q58408357-D9DE5258-F1F4-4587-85C0-62C8A33C6D24
publication date	2006-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58408357-0ABB283E-503F-4884-B792-62F13911CDE9
language of work or name	English
author name string	wds:Q58408357-C3A70F98-D9B0-4A7B-BA3E-DB381B4DE635 wds:Q58408357-EB5EBA75-F9E7-4CD0-B230-7BB9059C7542
author name string	Thierry Lecomte Bruno Landi
rdfs:label	Glutathione S-Transferase P1 Polymorphism (nl) Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy (en)
skos:prefLabel	Glutathione S-Transferase P1 Polymorphism (nl) Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy (en)
name	Glutathione S-Transferase P1 Polymorphism (nl) Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy (en)
author	wds:Q58408357-9099889C-640C-4BDF-AD46-70E75B90E290 wds:Q58408357-9B56528D-77AD-4AA4-A9B5-5C32D1574DFC wds:Q58408357-BFE932AF-119F-4767-A2D4-D11C14D672E8
author	Pierre Laurent-Puig Philippe Beaune Marie-Anne Loriot
title	wds:Q58408357-D855C2B8-55AC-4546-B88A-210D51645B18
title	Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy (en)
page(s)	wds:Q58408357-B4470AD9-C7AC-4716-8CB3-FD270A83857B
page(s)	3050-3056
instance of	wds:Q58408357-E463C40D-C310-4109-895E-FBED7FC452F0
instance of	scholarly article
main subject	wds:Q58408357-41879212-072C-4EF0-A3F1-DF46FA457D1F wds:Q58408357-5D312B5D-08DB-4894-9373-F0DAF52EB5BC wds:Q58408357-F1D3E681-3F60-44CA-AA21-FF996EA1A056
main subject	chemotherapy glutathione oxaliplatin
PubMed ID	wds:Q58408357-89AE1D3C-7D97-486B-B1FB-45FC3F3DBE14
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16707601
PubMed ID	16707601
published in	wds:Q58408357-A332F668-C63D-48B2-A4E6-232FE3DB099C
published in	Clinical Cancer Research
issue	wds:Q58408357-6114B439-C5AA-476D-83B5-A7DCB6EE3EAF
volume	wds:Q58408357-0FC2FB09-AF0E-45B8-8A53-464241D4AF8A
issue	10
volume	12
DOI	wds:Q58408357-C2EBC15F-4862-4AD7-B3E5-3BB6A7245F22
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-05-2076
DOI	10.1158/1078-0432.CCR-05-2076
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58408357
is cites work of	Genetic prognostic and predictive markers in colorectal cancer Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer Platinum-induced neurotoxicity and preventive strategies: past, present, and future Oxaliplatin-induced neuropathy in colorectal cancer Chemotherapy-induced neuropathy Glutathione s-transferase p1: gene sequence variation and functional genomic studies Chemotherapy-induced peripheral neurotoxicity: a critical analysis Pharmacogenetics in colorectal cancer: a systematic review Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants: simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant Alpha-class glutathione S-transferases in wild turkeys (Meleagris gallopavo): characterization and role in resistance to the carcinogenic mycotoxin aflatoxin B1 Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen Platinum neurotoxicity pharmacogenetics Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study Genetic polymorphism of GSTP1: prediction of clinical outcome to oxaliplatin/5-FU-based chemotherapy in advanced gastric cancer Informative gene network for chemotherapy-induced peripheral neuropathy Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients. Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Insights into the role of heritable genetic variation in the pharmacokinetics and pharmacodynamics of anticancer drugs Systemic therapy for metastatic colorectal cancer: current questions Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients Molecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications Predicting acute and persistent neuropathy associated with oxaliplatin Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors Pharmacogenetics and stomach cancer: an update. Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma Neurocognitive functioning and genetic variation in patients with primary brain tumours Pharmacogenomics in neurology: current state and future steps Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Chemotherapy-induced peripheral neuropathy: A current review Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients. AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs. Biomarker-based selection of therapy for colorectal cancer Associations analysis of GSTM1, T1 and P1 Ile105Val polymorphisms with carpal tunnel syndrome. Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software